Ferring is seeking a Commercial Lead - Uro-Oncology to drive the market access strategy and manage an established portfolio in the UK. This role offers full P&L ownership from day one and is critical for the upcoming launch of a novel intravesical gene therapy in 2027.
The ideal candidate will have robust experience in specialty pharmaceuticals, particularly in oncology or urology, along with demonstrated P&L management skills. Key responsibilities include developing market access strategies, engaging with insurers, and leading cross-functional initiatives.
#J-18808-Ljbffr